The SARS-CoV-2 Spike protein is often the main target of COVID-19 therapeutic research efforts. Yet, numerous other structural and non-structural proteins (NSPs) comprise the SARS-CoV-2 virus. A greater understanding of coronavirus-related antigens is critical for optimizing the research, development, and manufacturing of novel therapeutics and robust diagnostics. In this webinar sponsored by R&D Systems, part of the Bio-Techne Corporation, Anthony Person will discuss novel protein-based assays for COVID-19 and how they can advance diagnostic and therapeutic development.
Topics to be covered
Newly discovered genetic Spike variants, Spike glycosylation, ACE-2, proteases, and non NSPs
How new protein-based tools can help advance the development of clinical applications
Speaker Information:
Anthony Person, PhD
Sr. Director, Protein Business Unit
Bio-Techne
Interested in sponsoring a webinar? Click here to contact our friendly sales team.
